Investigating locally relevant risk factors for Campylobacter infection in Australia: Protocol for a case-control study and genomic analysis by Varrone, L. et al.
1Varrone L, et al. BMJ Open 2018;8:e026630. doi:10.1136/bmjopen-2018-026630
Open access 
Investigating locally relevant risk 
factors for Campylobacter infection in 
Australia: protocol for a case–control 
study and genomic analysis
Liana Varrone,1 Russell J Stafford,2 Kim Lilly,3 Linda Selvey,1 Kathryn Glass,4 
Laura Ford,4 Dieter Bulach,5,6 Martyn D Kirk,4 On behalf of The CampySource 
Project Team
To cite: Varrone L, Stafford RJ, 
Lilly K, et al.  Investigating 
locally relevant risk factors 
for Campylobacter infection 
in Australia: protocol for 
a case–control study and 
genomic analysis. BMJ Open 
2018;8:e026630. doi:10.1136/
bmjopen-2018-026630
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
026630). 
Received 17 September 2018
Revised 3 October 2018
Accepted 3 October 2018
For numbered affiliations see 
end of article.
Correspondence to
Dr Martyn D Kirk;  
 Martyn. Kirk@ anu. edu. au
Protocol
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction The CampySource project aims to identify 
risk factors for human Campylobacter infection in Australia. 
We will investigate locally relevant risk factors and those 
significant in international studies in a case–control study. 
Case isolates and contemporaneous isolates from food 
and animal sources will be sequenced to conduct source 
attribution modelling, and findings will be combined with 
the case–control study in a source-assigned analysis.
Methods and analysis The case–control study 
will include 1200 participants (600 cases and 600 
controls) across three regions in Australia. Cases will 
be recruited from campylobacteriosis notifications to 
health departments. Only those with a pure and viable 
Campylobacter isolate will be eligible for selection to allow 
for whole genome sequencing of isolates. Controls will 
be recruited from notified cases of influenza, frequency 
matched by sex, age group and geographical area of 
residence. All participants will be interviewed by trained 
telephone interviewers using a piloted questionnaire. We 
will collect Campylobacter isolates from retail meats 
and companion animals (specifically dogs), and all food, 
animal and human isolates will undergo whole genome 
sequencing. We will use sequence data to estimate the 
proportion of human infections that can be attributed to 
animal and food reservoirs (source attribution modelling), 
and to identify spatial clusters and temporal trends. 
Source-assigned analysis of the case–control study data 
will also be conducted where cases are grouped according 
to attributed sources.
Ethics and dissemination Human and animal ethics 
have been approved. Genomic data will be published 
in online archives accompanied by basic metadata. We 
anticipate several publications to come from this study.
IntroduCtIon  
Campylobacter infection is the most commonly 
notified cause of foodborne gastroenteritis 
in Australia,1–3 as well as a leading cause of 
bacterial gastroenteritis worldwide.4 At the 
introduction of Australia’s National Notifi-
able Diseases Surveillance System in 1991 the 
incidence rate of notified campylobacteriosis 
cases was 79.1/100 000 population,5 and 
despite notification rates plateauing in recent 
years, incidence had risen to 139.7/100 000 
population in Australia in 2015,5 with an esti-
mated 10 cases for every notified case within 
the community.6 Similarly, the incidence 
rate of campylobacteriosis in New Zealand 
in 2014 was 150.3/100 000 population,7 with 
an estimated 10–30 cases in the community 
for every notified case.8 Campylobacter notifi-
cation rates in Australia and New Zealand are 
still among the highest in the world across 
high-income countries. Most countries in the 
European Union consistently report annual 
campylobacteriosis notification rates below 
100/100 000 population.2 
Two species of Campylobacter—Campylobacter 
jejuni and C. coli—contribute to approximately 
95% of human campylobacteriosis.9 These 
Campylobacter spp are commonly detected 
in sewage and surface water,10 reside in the 
gastrointestinal tract of birds and animals11 
and are frequently found in raw meat, partic-
ularly poultry, and raw milk.12 13 Campy-
lobacteriosis is mostly foodborne, with an 
strengths and limitations of this study
 ► Case–control study is well powered to identify local-
ly relevant risk factors.
 ► Linking genomic data to the case–control study 
strengthens the analysis by enabling source attribu-
tion and source-assigned analyses to be conducted.
 ► Case–control questionnaire questions are being val-
idated in a separate study, demonstrating the reli-
ability of participant recall.
 ► Potential reporting bias due to inaccurate recall of 
study participants is a potential weakness of the 
study.
 ► Case–control study lacks efficiency for risk factors 
with high levels of exposure in the study population.
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estimated 77% of cases transmitted via food consumption 
in Australia.14 15 Direct and indirect zoonotic transmission 
can occur via animal contact (direct) or faecally contami-
nated water or environments (indirect). Person-to-person 
transmission is considered rare.16 The majority of cases 
are thought to be sporadic, with outbreaks less commonly 
detected.17 Most outbreaks are linked to the consumption 
of poultry, raw milk or contaminated water.17 18
Targeted control of foodborne bacterial pathogens 
generally depends on identification of sources and routes 
of transmission. Since Campylobacter are ubiquitous in the 
environment and most cases are sporadic, identifying 
sources is difficult. Source attribution methods require 
isolation of strains from reservoirs to compare Campylo-
bacter strain diversity in foods and animals with that in 
human infections. Beef, sheep and pig meat have a lower 
prevalence of Campylobacter contamination than chicken 
meat (<5%–14%),19–21 but a higher prevalence is found 
in animal offal such as liver,22 thus making offal a valu-
able source of host-associated strains of Campylobacter in 
low-prevalence meats.
study rAtIonAlE
In the USA, evidence from case–control studies has led 
to policy change, including changes to chicken slaugh-
tering techniques. The incidence of human Campylo-
bacter infection has declined in the USA since this policy 
was introduced in 1997.23 More recently, evidence from 
source attribution analyses in New Zealand has led to the 
development of poultry production policies and practices 
aimed at reducing the risk of Campylobacter transmission 
via poultry food products.24 New Zealand has seen a 74% 
reduction in the number of campylobacteriosis cases 
attributed to poultry in the region, as well as a 54% reduc-
tion in cases overall.25
Source attribution modelling enables us to determine 
which foods and animals are the most likely sources of 
infection with each Campylobacter strain type, and the 
proportion of cases attributed to each source. This can 
be done with simple proportional similarity index (PSI) 
calculations, or by using more complex models.24 Source 
attribution also allows for human campylobacteriosis 
cases to be grouped by potential source, increasing the 
specificity of risk factor analyses. These source-assigned 
analyses combine the epidemiological information 
gained through the traditional case–control study with 
source attribution modelling to provide greater explana-
tory power to investigate locally relevant risk factors.
objECtIvEs
This study aims to:
1. Identify dietary, environmental and behavioural risk 
factors for Campylobacter infection in Australia.
2. Strengthen the epidemiological evidence for previous-
ly identified risk factors in Australia.
3. Identify strain-specific risk factors for infection using 
whole genome sequencing (WGS) data from case 
isolates.
HypotHEsEs
We will test several hypotheses regarding specific risk 
factors for Campylobacter infection in Australia. The 
hypotheses are based on exposures that have previously 
been identified as risk factors for Campylobacter infection 
in Australia as well as internationally.
We hypothesise that:
1. Persons who consume undercooked meats, particular-
ly chicken, are at increased risk of infection.
2. Persons who consume offal are at increased risk of in-
fection.
3. Persons who own companion animals (especially pup-
pies) are at increased risk of infection.
4. Poor food hygiene and handling practices in the home 
increase the risk of infection.
5. Most human infections will be attributed to consump-
tion of chicken meat.
6. There will be a high level of genetic diversity among 
Campylobacter strains.
study dEsIgn
We will conduct a case–control study including 
genomic testing over a 2-year period in three sentinel 
sites: the state of Queensland (QLD), the Australian 
Capital Territory (ACT) and the Hunter New England 
(HNE) region of New South Wales (figure 1). Sporadic 
cases of culture-positive Campylobacter infection will be 
identified either through state notifiable disease regis-
ters, from local pathology service databases or local 
notification databases. An isolate from each case will 
be paired with epidemiological data from the case 
interview. One control will be recruited for each case 
who participates in the study, with trained interviewers 
conducting telephone interviews with both cases and 
Figure 1 Map of Australian states and territories including 
the Hunter New England region of New South Wales.
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controls. Participants will be interviewed using a ques-
tionnaire that has been specifically designed to collect 
information on known potential risk factors. This ques-
tionnaire will include a selection of questions being 
validated in a separate study (LV: Validation of ques-
tions designed for investigation of gastroenteritis). For 
cases, the questions will cover the 7 days prior to the 
onset of illness, while controls will be questioned on 
the 7 days prior to interview. Meanwhile, Campylobacter 
isolates will also be collected from food and animal 
samples. All human and non-human isolates will 
undergo WGS for comparison in source attribution 
modelling. Data for this study will be collected from 1 
March 2017 to 1 March 2019.
patient and public involvement
To develop the study, we engaged state and territory 
health departments, food safety agencies and industry 
to establish research questions and methods. The 
process involved a dedicated workshop, followed by 
teleconferences and an iterative process of drafting 
study documentation. We also established a reference 
panel, which includes representatives from senior 
levels of government and industry bodies. No patients 
or other members of the public were involved in the 
development of this study.
study populAtIon
The three sentinel sites cover a population of approxi-
mately 6.1 million people. Based on notification and 
diagnostic pathology data, we expect approximately 8650 
Campylobacter cases to be notified across these sites during 
the study period.
dEfInItIon And sElECtIon of CAsEs
Case definition
We define a case as a person from any of the three partic-
ipating sites with a history of acute diarrhoea and a 
culture-positive stool result for Campylobacter.
sAMplE sIzE
We used risk factor prevalence data from a previous 
national Campylobacter case–control study in 2001/2002 
to estimate sample size for this study.26 For example, the 
prevalence of chicken consumption among controls in 
2001/2002 was 80%. A sample size of approximately 1040 
subjects (520 cases; 520 controls) would enable the study 
to detect an association between chicken consumption 
and illness with an OR of 1.6, at 80% power and α=0.05, 
as reported in the previous study. Sample size estimates 
for other potential risk factors are listed in table 1.
From these calculations, we estimate that a study of 
1200 subjects (600 cases; 600 controls) will adequately 
detect significant associations of these magnitudes for 
potential risk factors of interest. QLD and HNE sites will 
each enrol at least 250 cases into the study, while ACT 
will enrol at least 100 cases. Based on the previous Austra-
lian case–control study,26 we expect approximately 80% 
of selected notified cases to be eligible and participate in 
the study (table 2).
In QLD, we will obtain cases from one private pathology 
provider reporting approximately 40% of the state’s 
Campylobacter notifications. We estimate that this provider 
will notify 2800 cases during the study period with an esti-
mated 45% of these being culture positive (1260 notified 
cases). In ACT, approximately 600 Campylobacter noti-
fications are expected during the study period; 130 are 
expected from the participating pathology laboratory. In 
Table 1 Sample size estimates for an unmatched case–
control study
Risk factor
Prevalence 
of exposure 
among 
controls (%)
Prevalence 
of exposure 
among 
cases (%) OR
Number of 
required 
study 
subjects
Beef 78 85 1.6 960
Pork 52 60 1.4 1130
Lamb 42 50 1.4 1120
Chicken 80 87 1.6 1040
Offal 2.0 5.0 2.6 1154
Puppies 2.1 5.4 2.7 1040
80% power and α=0.05.
Table 2 Sampling method for cases in each site
State
Expected number 
of notified cases 
during study 
period
Estimated cases 
from participating 
pathology 
laboratory
Culture-
positive 
cases
Sequential sampling of 
notified cases
Total 
number 
of cases
Expected 
number to be 
recruited (~80% 
participation rate)
QLD 7000 2800 1260 Select every fourth case 315 250
ACT 600 130 130 Include all notified cases 130 100
NSW (Hunter 
New England)
1050 313 313 Include all notified cases 313 250
Total 8650 3243 1703 758 600
ACT, Australian Capital Territory; NSW, New South Wales; QLD, Queensland.
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HNE, approximately 1050 Campylobacter notifications are 
expected during the study period; 313 of these notifica-
tions will be from the participating pathology laboratory.
Enrolment of cases
We will enrol all cases who meet the eligibility criteria 
(table 3). Each site will check for new notifications of 
culture-positive Campylobacter infection daily, with only 
culture-positive Campylobacter cases eligible for this study. 
If a case refuses to participate in the study, we will select 
a subsequent case for inclusion. Enrolment of cases will 
require consent from the patient, or in the event of a 
child aged less than 18 years, consent from either one 
of the parents or the child’s guardian. We will interview 
cases as soon as possible by telephone, preferably within 
2 weeks of notification from the laboratory. It will be at 
the parent’s or guardian’s discretion as to whether a child 
aged between 15 and 17 years is interviewed directly. The 
parent or guardian will be interviewed for cases aged less 
than 15 years.
dEfInItIon And sElECtIon of Controls
We will recruit controls from notified cases of influenza, 
frequency matched by sex, age group and geographical 
area of residence by statistical area level 4 (SA4). These 
controls will be selected with a delay of at least 6 months 
from their influenza infection to ensure that controls 
have returned to eating their customary diet.
Each participating site (QLD, ACT or HNE) will estab-
lish a database of controls (previous influenza cases). All 
cases of influenza notified to the health department in 
each site between 1 January and 31 December 2017 will be 
entered into this control database. The age bands are 0–4 
years, 5–14 years, 15–34 years, 35–54 years, 55–74 years 
and ≥75 years. An appropriate control will be randomly 
selected from the database within 30 days of interview of 
the notified case.
Case and control recruitment
Interviewers trained in computer-assisted telephone inter-
viewing will conduct telephone interviews. A maximum 
of six attempts will be made to contact any one case or 
control, with no more than three attempts in any one day. 
Three calls will be attempted between 09:00 and 15:59, 
and three attempts between 16:00 and 20:00. A text 
message will be sent to the potential participant after 
three failed call attempts, indicating that Public Health 
is trying to contact them. This protocol will be continued 
until the person is enrolled or excluded.
QuEstIonnAIrEs
We will use specific case and control questionnaires for 
all participants (see online supplementary appendix 1). 
Cases will be asked additional questions about the clin-
ical course of their illness and treatment. Interviewers will 
ask identical questions regarding exposures such as foods 
consumed, dining locations, water sources, domestic 
food handling techniques and exposure to animals of 
cases and controls. Questions on foods consumed, dining 
locations, water consumed and animal and pet exposures 
will be asked based on a 7-day history. Questions on inter-
national travel will be asked based on a 2-week history. 
Antibiotic and antacid consumption, immunosuppres-
sive treatment and household history of diarrhoea will be 
based on a 4-week history. Questions on food handling 
and general kitchen practices will be based on usual 
Table 3 Eligibility criteria for cases and controls
Criteria Cases Controls
Had diarrhoea (≥3 loose bowel movements in 24 hours) Include Exclude
Known date of illness onset Include NA
Household members positive for Campylobacter in 4 weeks prior to onset of illness Exclude Exclude (4 weeks prior 
to interview date)
Household members experiencing diarrhoea in 4 weeks prior to onset of illness Exclude Exclude (4 weeks prior 
to interview date)
Travelled outside of Australia in 2 weeks prior to onset of illness Exclude Exclude (2 weeks prior 
to interview date)
Travelled interstate for the entire 2 weeks prior to onset of illness Exclude Exclude (2 weeks prior 
to interview date)
Cannot speak English Exclude Exclude
Not able to answer questions for some other reason (eg, intellectually disabled) Exclude Exclude
Not contactable after six telephone attempts Exclude Exclude
Live outside the catchment areas Exclude Exclude
Do not have a telephone number available for their primary residence, or a mobile phone Exclude Exclude
An enteric pathogen other than Campylobacter was isolated/detected in their stool 
(excluding Blastocystis hominis and Dientamoeba fragilis)
Exclude NA
NA, not applicable.
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practices rather than recent history. Demographic infor-
mation will be collected from cases and controls. Contact 
information required to conduct interviews will be stored 
in a password-protected Excel document with only those 
needing to contact individuals given access. Piloted ques-
tionnaires were modified to remove repetitions, improve 
clarity and to ensure that interviews could be conducted 
within 20 min.
dAtA HAndlIng And rIsk fACtor AnAlysIs
We will undertake descriptive reporting of campylobac-
teriosis incidence by person, place and time. We will also 
describe the severity of symptoms, treatment and burden 
of illness.
Risk factor analysis will involve the examination of 2×2 
contingency tables with Χ2 or exact tests to determine the 
presence of univariable associations between variables 
and disease. To measure the strength of an association, 
we will estimate ORs and calculate 95% CIs in a univari-
able analysis, followed by multivariable logistic regres-
sion modelling to adjust for potential confounders. Risk 
factors selected for inclusion in the regression model will 
include age, season and geographic area, variables with a 
significant univariable association with disease, and vari-
ables with a p value ≤0.25 that are biologically plausible 
and of interest to the research team.
lAborAtory AnAlysEs
Human samples
As outlined in table 2, it is expected that 250 human 
isolates from HNE, 250 from QLD and 100 from ACT 
will be sequenced, with an additional 100 isolates being 
sourced from Victoria. The initial isolation and confirma-
tion of Campylobacter infection will be performed locally in 
each state/territory. Only samples with a pure and viable 
culture will undergo WGS.
We will also collect an additional 20 – 30  human isolates 
from four Australian jurisdictions not participating in this 
case – control study to undergo WGS. This will be done 
over a  2- month  period that overlaps with the case – 
control study sample collection, and is planned to help 
inform the generalisability of the case – control study. 
Animal and food samples
We will collect samples from chicken meat (covering the 
two production methods of continually housed and free 
range/housed), beef, lamb, pork and pet dogs. Given low 
prevalence of Campylobacter in meats other than chicken, 
samples will be collected from offal (preferably liver) from 
bovine, ovine and porcine sources to ensure sufficient posi-
tive samples are obtained for the study. Given the rising 
importance of chicken liver pate as a source of outbreaks 
in Australia,27 chicken offal will also be sampled. Sample 
sizes by source are based on data from two states to ensure 
50 positive samples per food source, and 30 samples in 
companion animals (table 4). We will also contact veter-
inary clinics and teaching hospitals to ensure sufficient 
Campylobacter-positive samples from dogs. Water samples 
have been omitted from the genomic aspect of this study 
due to logistical constraints in sampling untreated water 
sources across the large geographical area involved in this 
study, and the complexity of designing an appropriate 
sampling frame. As there is a lack of evidence implicating 
municipal drinking water as sources of Campylobacter 
infection in Australia1 26 we excluded water sampling 
from this study.
The initial isolation and confirmation of Campylo-
bacter will be performed locally at laboratories in each 
state/territory, with isolates forwarded to the Microbi-
ological Diagnostic Unit Public Health Laboratory for 
WGS, except QLD isolates which will be sequenced at 
Queensland Health. To detect seasonal and temporal 
variation in Campylobacter genetic types, 1041 food and 
animal samples (estimated to produce 330 Campylobacter 
isolates) will be collected over a period of 1 year in QLD, 
and 2 years in New South Wales. To assess latitudinal vari-
ation in chicken meat samples across eastern Australia, 
105 chicken samples (70 chicken meat and 35 chicken 
offal) will be collected over a 6-month period in Victoria. 
Food samples will be collected monthly from retail prem-
ises, using protocols from surveys undertaken in 2014 by 
partner organisations, with a pilot of 30 isolates in QLD.
sEQuEnCIng And sEQuEnCE dAtA proCEssIng
Campylobacter isolates selected for sequencing will be repu-
rified on solid medium and a single colony selected for 
preparation of genomic DNA. A sequencing library will 
be prepared from the genomic DNA for sequencing on 
the Illumina sequencing platform (MiSeq or NextSeq). 
A sample of the selected colony will be regrown and cryo-
preserved (resuspended in liquid medium supplemented 
with 10% glycerol and stored at −80°C). In some cases, 
Table 4 Sampling to ensure 50 isolates per food source and 30 isolates from companion animals
Foods Animals
Chicken Beef Lamb Pork
Dogs TotalContinually housed Free range Offal Offal Offal Offal
Assumed prevalence 0.7 0.7 0.7 0.14 0.6 0.22 0.2
Samples required 72 72 72 286 100 272 150 1041
Positive isolates 50 50 50 40 60 60 30 330
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Campylobacter enrichment cultures will be cryopreserved 
to enable future investigation of the genetic diversity of 
Campylobacters present. The short-read, paired-end data set 
produced by the Illumina Instrument from the genomic 
DNA of each isolate will be processed to produce a draft 
genome sequence for the isolate using a de novo assem-
bler such as MEGAHIT.28 The draft genome sequence will 
be annotated using Prokka.29 We will use the draft genome 
sequence to perform the initial subspecies classification 
by deriving a multilocus sequence type (MLST) using the 
‘Campylobacter jejuni/coli’ typing scheme ( pubmlst. org). 
Again, using the draft genome sequence, further typing, 
for example, virulence factors (http://www. mgc. ac. cn/ 
VFs/) or antimicrobial resistance genotype (https:// 
cge. cbs. dtu. dk/ services/ ResFinder/), will be performed 
using Abricate (https:// github. com/ tseemann/ abri-
cate). We will perform comparative genomics to examine 
the genetic relationships between selected subgroups of 
isolates in more detail using Nullarbor (https:// github. 
com/ tseemann/ nullarbor).
sourCE AttrIbutIon ModEllIng
We will analyse the epidemiological data within desig-
nated MLST groups or other typing groups derived from 
the genomic sequence data. Source attribution model-
ling and source-assigned analyses will be conducted.
Source attribution models combine typing data from 
isolates from food, animals and humans to estimate the 
proportion of human infections that can be attributed 
to animal and food reservoirs.30 31 Once inferred MLSTs 
have been ascertained, the PSI25 will be used to assess 
similarities by source. We will then undertake source attri-
bution analyses by adapting the asymmetric island model 
which has previously been applied to MLST data25 32 using 
Markov chain Monte Carlo methods33 implemented using 
the free software WinBUGS.34 These methods will first 
be applied to MLST data extracted from whole genome 
sequences (the aforementioned ‘inferred MLSTs’), and 
then compared with structured phylogenetic modelling 
approaches35 36 that provide scope to infer interhost 
transmission.
We will then group cases according to putative source 
based on these source attribution methods.37 For example, 
all isolates attributed to chicken will be grouped together, 
regardless of differing strains. These cases attributed to 
chicken will then be compared with all controls in a risk 
factor analysis to produce a source-assigned analysis.
spAtIAl ClustErs And tEMporAl trEnds
We will use newly designated WGS-based MLSTs to 
assess heterogeneity in isolates from food sources and 
companion animals in QLD and New South Wales, and 
in isolates from chicken meat and humans across QLD, 
New South Wales, Victoria and ACT. A 2-year sampling 
framework in New South Wales, 1 year of sampling in 
QLD and previous survey work in these states will allow 
us to assess the extent of seasonal and temporal trends. 
Postcode-level data associated with human illnesses will 
be used to detect space-time clusters using a scan statistic 
implemented in the free software SaTScan, at the SA1.38 
We will use a retrospective space-time permutation model 
to detect high-risk clusters by comparing the observed 
number of illnesses with the expected number in that 
geographic zone and time period.39
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